R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy

Rituximab, cyclophosphamide, etoposide, vincristine, prednisone antineoplastic chemotherapy regimen (regime/therapy)

regime/therapy
£1.00

Supplier: international · SCTID 1141994004

Also known as (2)
  • RCEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy
  • Rituximab, cyclophosphamide, etoposide, vincristine, prednisone antineoplastic chemotherapy regimen

Found in

Administration of mitotic inhibitor Antineoplastic chemotherapy regimen Corticosteroid and/or corticosteroid derivative therapy Cyclophosphamide therapy Hormone therapy Rituximab therapy

Related products

Ablative hormone therapy
£1.00
ABVD chemotherapy regimen
£1.00
Administration of prophylactic combined calcium and vitamin D3 preparation
£1.00
Androgen deprivation therapy
£1.00
Antenatal therapeutic administration of corticosteroid
£1.00
Antineoplastic chemoimmunotherapy
£1.00
Basal insulin regime
£1.00
Basal-bolus insulin regime
£1.00
Basal-plus preprandial insulin regime
£1.00
Controlled ovarian stimulation
£1.00
FOLFIRI antineoplastic chemotherapy regimen
£1.00
Hormone manipulation
£1.00
Hormone replacement therapy
£1.00
Initiation of first time insulin therapy
£1.00
Intensification antineoplastic therapy regimen
£1.00
Internal iliac artery vasopressin infusion
£1.00
Intramuscular calcitonin therapy
£1.00
Intramuscular hormone therapy
£1.00
Intravenous hydrocortisone therapy
£1.00
Leuprorelin therapy
£1.00
Levothyroxine therapy
£1.00
Maintenance antineoplastic therapy
£1.00
Methylprednisolone pulse therapy
£1.00
Neoadjuvant endocrine therapy
£1.00
Basket
Total£0.00